Technology

Veracyte

$53.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-0.37%) Today
$0.00 (0.00%) As of 9:02 PM UTC after-hours

Why Robinhood?

You can buy or sell Veracyte and other stocks, options, and ETFs commission-free!

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA. The listed name for VCYT is Veracyte, Inc. Common Stock.

CEO
Bonnie H. Anderson
Employees
354
Headquarters
South San Francisco, California
Founded
2006
Market Cap
2.97B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
727.23K
High Today
$55.28
Low Today
$50.94
Open Price
$54.82
Volume
766.38K
52 Week High
$63.55
52 Week Low
$13.90

Collections

VCYT Earnings

-$0.24
-$0.16
-$0.08
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 23, After Hours

You May Also Like

PAVMZ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure